Open Access
| Issue |
BIO Web Conf.
Volume 60, 2023
2022 4th International Conference on Biotechnology and Food Science (BFS 2022)
|
|
|---|---|---|
| Article Number | 01004 | |
| Number of page(s) | 8 | |
| Section | Biochemical Application and Genetic Engineering | |
| DOI | https://doi.org/10.1051/bioconf/20236001004 | |
| Published online | 11 May 2023 | |
- Andersson, T., Miners, J. O., Veronese, M. E., Tassaneeyakul, W., Tassaneeyakul, W., Meyer, U. A., & Birkett, D. J. (1993). Identification of human liver cytochrome P450 isoforms mediating omeprazole metabolism. British journal of clinical pharmacology, 36(6), 521-530. [CrossRef] [PubMed] [Google Scholar]
- Andersson, T., Cederberg, C., Reg» rdh, C. G., & Sk»nberg, I. (1990). Pharmacokinetics of various single intravenous and oral doses of omeprazole. European journal of clinical pharmacology, 39, 195-197. [CrossRef] [PubMed] [Google Scholar]
- Armani, S., Ting, L., Sauter, N., Darstein, C., Tripathi, A. P., Wang, L., ... & Kulkarni, S. (2017). Drug interaction potential of osilodrostat (LCI699) based on its effect on the pharmacokinetics of probe drugs of cytochrome P450 enzymes in healthy adults. Clinical drug investigation, 37, 465-472. [CrossRef] [PubMed] [Google Scholar]
- Darwish, M., Kirby, M., Robertson, P., & Hellriegel, E. T. (2008). Interaction profile of armodafinil with medications metabolized by cytochrome P450 enzymes 1A2, 3A4 and 2C19 in healthy subjects. Clinical pharmacokinetics, 47, 61-74. [CrossRef] [PubMed] [Google Scholar]
- Dumond, J. B., Vourvahis, M., Rezk, N. L., Patterson, K. B., Tien, H. C., White, N., ... & Kashuba, A. D. M. (2010). A Phenotype–Genotype Approach to Predicting CYP450 and P‐Glycoprotein Drug Interactions With the Mixed Inhibitor/Inducer Tipranavir/Ritonavir. Clinical Pharmacology & Therapeutics, 87(6), 735-742. [CrossRef] [PubMed] [Google Scholar]
- Foster, D. M., & Vicini, P. (2022). Noncompartmental and compartmental approaches to pharmacokinetic data analysis. In Atkinson’s Principles of Clinical Pharmacology (pp. 113-135). Academic Press. [CrossRef] [Google Scholar]
- Kanazawa, H., Okada, A., Matsushima, Y., Yokota, H., Okubo, S., Mashige, F., & Nakahara, K. (2002). Determination of omeprazole and its metabolites in human plasma by liquid chromatography–mass spectrometry. Journal of Chromatography A, 949(12), 1-9. [CrossRef] [PubMed] [Google Scholar]
- Landahl, S., Andersson, T., Larsson, M., Lernfeldt, B., Lundborg, P., Regårdh, C. G., ... & Skånberg, I. (1992). Pharmacokinetic study of omeprazole in elderly healthy volunteers. Clinical pharmacokinetics, 23(6), 469-476. [CrossRef] [PubMed] [Google Scholar]
- Lorentzon, P., Eklundh, B., Brändström, A., & Wallmark, B. (1985). The mechanism for inhibition of gastric (H++ K+)-ATPase by omeprazole. Biochimica et Biophysica Acta (BBA)Biomembranes, 817(1), 25-32. [CrossRef] [Google Scholar]
- Marzo, A., Ceppi Monti, N., & Vuksic, D. (1999). Experimental, extrapolated and truncated areas under the concentration–time curve in bioequivalence trials. European journal of clinical pharmacology, 55, 627-631. [CrossRef] [PubMed] [Google Scholar]
- Mehraban, M. S. A., Shirzad, M., Ahmadian-Attari, M. M., Shakeri, R., Kashani, L. M. T., Tabarrai, M., & Shirbeigi, L. (2021). Effect of rose oil on gastroesophageal reflux disease in comparison with omeprazole: a double-blind controlled trial. Complementary Therapies in Clinical Practice, 43, 101-361. [Google Scholar]
- Niessen, W. M., & Falck, D. (2015). Introduction to mass spectrometry, a tutorial. Analyzing biomolecular interactions by mass spectrometry, 154. [Google Scholar]
- Omeprazole. In: Wikipedia.; 2021. Accessed January 6, 2022. https://en.wikipedia.org/w/index.php?title=Omeprazole&oldid=1059783996 [Google Scholar]
- Regårdh, C. G. (1986). Pharmacokinetics and metabolism of omeprazole in man. Scandinavian Journal of Gastroenterology, 21(sup118), 99-104. [CrossRef] [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.